VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 385 filers reported holding VANECK VECTORS ETF TR in Q4 2017. The put-call ratio across all filers is 1.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $455 | -93.9% | 16,900 | -93.2% | 0.01% | -91.1% |
| Q2 2023 | $7,465 | -11.3% | 247,929 | -4.7% | 0.06% | -42.9% |
| Q1 2023 | $8,420 | -48.5% | 260,269 | -54.3% | 0.10% | -50.8% |
| Q4 2022 | $16,334 | -99.9% | 569,933 | -1.6% | 0.20% | +15.0% |
| Q3 2022 | $13,971,000 | +100.9% | 579,215 | +128.0% | 0.17% | +133.8% |
| Q2 2022 | $6,954,000 | -61.9% | 253,994 | -46.6% | 0.07% | -44.8% |
| Q1 2022 | $18,241,000 | +12.9% | 475,650 | -5.7% | 0.13% | +52.3% |
| Q4 2021 | $16,151,000 | +44.2% | 504,240 | +32.7% | 0.09% | +66.0% |
| Q3 2021 | $11,201,000 | -75.5% | 380,077 | -71.7% | 0.05% | -75.1% |
| Q2 2021 | $45,698,000 | +78.7% | 1,344,848 | +70.9% | 0.21% | +59.0% |
| Q1 2021 | $25,571,000 | -79.9% | 786,813 | -77.7% | 0.13% | -80.3% |
| Q4 2020 | $127,350,000 | +9951.3% | 3,535,548 | +10826.0% | 0.68% | +8400.0% |
| Q3 2020 | $1,267,000 | -82.2% | 32,359 | -83.3% | 0.01% | -86.4% |
| Q2 2020 | $7,109,000 | -17.7% | 193,822 | -48.3% | 0.06% | -27.2% |
| Q1 2020 | $8,641,000 | +2705.5% | 375,026 | +3469.3% | 0.08% | +2600.0% |
| Q4 2019 | $308,000 | -99.3% | 10,507 | -99.3% | 0.00% | -99.1% |
| Q3 2019 | $41,964,000 | +242.7% | 1,571,088 | +227.9% | 0.34% | +309.5% |
| Q2 2019 | $12,245,000 | -51.2% | 479,069 | -57.2% | 0.08% | -63.6% |
| Q1 2019 | $25,084,000 | -6.0% | 1,118,844 | -11.6% | 0.23% | -0.9% |
| Q4 2018 | $26,682,000 | -77.5% | 1,265,151 | -80.3% | 0.23% | -73.5% |
| Q3 2018 | $118,667,000 | +116.3% | 6,407,518 | +160.6% | 0.88% | +77.9% |
| Q2 2018 | $54,863,000 | +8.4% | 2,459,141 | +6.8% | 0.49% | +22.0% |
| Q1 2018 | $50,629,000 | +8797.9% | 2,303,428 | +9300.2% | 0.40% | +8000.0% |
| Q4 2017 | $569,000 | -97.1% | 24,504 | -97.1% | 0.01% | -97.1% |
| Q3 2017 | $19,352,000 | +26.2% | 842,836 | +21.3% | 0.17% | +23.2% |
| Q2 2017 | $15,339,000 | -71.5% | 694,682 | -70.6% | 0.14% | -71.0% |
| Q1 2017 | $53,846,000 | +87.3% | 2,360,632 | +71.8% | 0.48% | +97.5% |
| Q4 2016 | $28,742,000 | +1601.7% | 1,373,909 | +2049.5% | 0.24% | +1238.9% |
| Q3 2016 | $1,689,000 | -63.0% | 63,917 | -61.3% | 0.02% | -43.8% |
| Q2 2016 | $4,571,000 | – | 164,967 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |